Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer.
McDevitt MR, Thorek DLJ, Hashimoto T, Gondo T, Veach DR, Sharma SK, Kalidindi TM, Abou DS, Watson PA, Beattie BJ, Timmermand OV, Strand SE, Lewis JS, Scardino PT, Scher HI, Lilja H, Larson SM, Ulmert D.
McDevitt MR, et al. Among authors: beattie bj.
Nat Commun. 2018 Apr 24;9(1):1629. doi: 10.1038/s41467-018-04107-w.
Nat Commun. 2018.
PMID: 29691406
Free PMC article.